IPP Bureau
Briefs: Alembic Pharmaceuticals and Relonchem
By IPP Bureau - July 05, 2024
Alembic Pharmaceuticals receives 11 USFDA product approval during Q1 FY2025
Evonik appoints Yann d’Herve as new head of Health Care business line
By IPP Bureau - July 04, 2024
Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1
Health Ministry issues advisory to states in view of zika virus cases from Maharashtra
By IPP Bureau - July 04, 2024
States urged to maintain a state of constant vigil through screening of pregnant women for Zika virus infection and monitoring the growth of foetus of expecting mothers who tested positive for Zika
Dr. B.N. Gangadhar appointed as Chairperson of the National Medical Commission
By IPP Bureau - July 04, 2024
Dr. Sanjay Behari, Director of Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, as the President of the Medical Assessment and Rating Board
Cupid Partners with SAP to Implement Advanced ERP System, SAP S/4HANA Cloud
By IPP Bureau - July 03, 2024
The integration of SAP S/4HANA Cloud will equip Cupid Limited with a comprehensive suite of integrated applications,
Aster Pharmacy to provide free random Blood Sugar and Blood Pressure check-ups at all its pharmacy outlets
By IPP Bureau - July 03, 2024
The initiative aims to empower individuals to take proactive steps towards monitoring their health
Aster Whitefield Hospital and government partner for free epilepsy camp in Kolar
By IPP Bureau - July 03, 2024
The initiative aimed to reach and support individuals suffering from epilepsy through early detection and effective disease management
Sipavibart EMA regulatory submission accepted under accelerated assessment for COVID-19 prevention
By IPP Bureau - July 03, 2024
Submission based on positive SUPERNOVA Phase III trial data which demonstrated a statistically significant reduction in the incidence of COVID?19 in an immunocompromised patient population
Avallano appoints Michael A. Ibara as Chief Strategy Officer
By IPP Bureau - July 03, 2024
Ibara will drive AI-powered clinical research innovation
LG Chem enters Chinese osteoarthritis treatment market
By IPP Bureau - July 03, 2024
Partners with Yifan Pharmaceutical to launch Synovian injection for osteoarthritis in China
Abbott and YRGCARE inaugurate new outreach centers in India
By IPP Bureau - July 02, 2024
Offering testing, treatment and support to help stop the spread of HIV and other infectious diseases
Lynparza and Imfinzi combination recommended for approval in the EU by CHMP for recurrent endometrial cancer
By IPP Bureau - July 02, 2024
Imfinzi also recommended for patients with mismatch repair deficient disease
Merck and Orion announce option providing Merck global exclusive rights to Opevesostat
By IPP Bureau - July 02, 2024
An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer
DKSH and Kimberly-Clark Partner to Launch Huggies Baby and Childcare Products in Cambodia
By IPP Bureau - July 02, 2024
DKSH’s Business Unit Consumer Goods further capitalizes on its position to strengthen the consumer health, nutrition, and baby care categories
